Gene: DICER1
Official Full Name: dicer 1, ribonuclease IIIprovided by HGNC
Gene Summary: This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00479 | DICER1 knockout cell line (HCT 116) | Human | DICER1 | 1:2~1:4 | Negative | Online Inquiry |
KO02238 | DICER1 Knockout cell line (HeLa) | Human | DICER1 | 1:3~1:6 | Negative | Online Inquiry |
KO02239 | DICER1 Knockout cell line (HEK293) | Human | DICER1 | 1:3~1:6 | Negative | Online Inquiry |
KO02240 | DICER1 Knockout cell line (A549) | Human | DICER1 | 1:3~1:4 | Negative | Online Inquiry |
DICER1 Gene Knockout Cell Lines are genetically engineered cell lines in which the DICER1 gene, a critical component in the microRNA (miRNA) pathway, has been selectively disrupted. This gene encodes an RNase III-type enzyme essential for the processing of precursor miRNAs into their active forms. By knocking out DICER1, researchers can effectively study the functional consequences of diminished miRNA biogenesis, allowing for a deeper understanding of gene regulation, cell differentiation, and the role of miRNAs in various physiological and pathological processes.
These cell lines serve as powerful tools for elucidating the mechanisms underlying various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, where miRNA dysregulation is often implicated. The absence of functional DICER1 provides a unique experimental model to investigate the roles of specific miRNAs, particularly in studies aimed at therapeutic interventions or molecular pathway analysis, making these cell lines invaluable in both basic and translational research settings.
What sets our DICER1 Gene Knockout Cell Lines apart from alternatives is the specificity and reliability of the gene-editing process, achieved through cutting-edge CRISPR/Cas9 technology. This ensures a precise knockout with minimal off-target effects, maintaining the integrity of other cellular functions. Moreover, the availability of these lines in multiple cellular backgrounds allows researchers to select the most appropriate model for their specific applications, enhancing the versatility of experimental designs.
For researchers and clinicians, these cell lines offer significant value by enabling comprehensive investigations into miRNA functions that can lead to novel therapeutic strategies and enhanced understanding of disease mechanisms. As experts in biogenetic engineering, our company is dedicated to supplying high-quality biological products that facilitate groundbreaking research, and the DICER1 Gene Knockout Cell Lines exemplify our commitment to innovation and excellence in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.